Liberty Wealth Management LLC Dexcom Inc Transaction History

Liberty Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$129.87 - $162.82 $22,597 - $28,330	-174 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $12,698 - $17,038	119 Added 216.36%	174 $102,000
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $1.9 Million - $2.53 Million	-23,430 Reduced 99.77%	55 $23,000
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $1.9 Million - $2.53 Million	23,476 Added 260844.44%	23,485 $55,000
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $78 - $104	1 Added 12.5%	9 $3,000
Q3 2020 Nov 05, 2020	BUY	$95.51 - $112.95 $764 - $903	8 New	8 $3,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.